Loading clinical trials...
Loading clinical trials...
Prospective, Multicenter, Randomized Open Study to Evaluate the Progression of Renal Graft Fibrosis According to the Epithelial-mesenchymal Transition (EMT) in de Novo Renal Transplant Recipients Treated Either by a CNI Free Immunosuppressive Regimen With Everolimus and Enteric-coated Mycophenolate Sodium or a CNI Based Regimen With Cyclosporine and Enteric-coated Mycophenolate Sodium
Conditions
Interventions
Certican®
Neoral
+3 more
Locations
23
France
Novartis Investigative Site
Caen, Cedex, France
Novartis Investigative Site
Angers, France, France
Novartis Investigative Site
Suresnes, France, France
Novartis Investigative Site
Amiens Cedex1, France
Novartis Investigative Site
Bordeaux, France
Novartis Investigative Site
Brest, France
Start Date
September 1, 2009
Primary Completion Date
June 1, 2012
Completion Date
June 1, 2012
Last Updated
March 18, 2014
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions